Fig. 4From: Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignanciesKaplan–Meier plots indicating survival in UCEC patients (A) and in THYM patients (B) associated with high- and low-expression levels of PD-1 and TIGIT, respectively. Continuous lines indicate high-level expressing patients; dashed lines indicate low-level expressing patientsBack to article page